文献速递烧伤创面修复

伊洛前列素治疗降低烧伤截肢率的疗效分析

Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn.
PubMed 文献 · J Burn Care Res · 2021-01-01

回顾性分析2016至2019年366例成年烧伤患者,比较接受与未接受伊洛前列素治疗者的截肢率。60例(16.3%)存在血管损伤,其中21例(35%)接受伊洛前列素治疗;全部患者中20例(5.5%)截肢,伊洛前列素组仅1例截肢(P < 0.001)。作者认为伊洛前列素可有效减少烧伤所致截肢。

要点

  • 烧伤合并血管损伤患者中,伊洛前列素治疗与截肢率显著降低相关(P < 0.001)
  • 电击伤(11.7%)与冻伤(3.3%)的血管损伤发生率高于热力烧伤(P < 0.001)
  • 全部366例中截肢20例(5.5%),伊洛前列素组仅1例

核心结论

  • 作者认为伊洛前列素治疗对减少烧伤所致截肢有效。
  • 伊洛前列素组截肢例数明显少于未治疗组(P < 0.001)。

研究设计与样本

  • 回顾性分析2016至2019年本院急诊收治的366例成年烧伤患者资料。
  • 记录人口学特征、烧伤因素、血管检查结果、内科治疗、截肢率及截肢平面。
  • 比较接受与未接受伊洛前列素治疗患者的截肢率。

主要发现

  • 366例平均年龄37.8 ± 16.4岁,其中220例(59.9%)小于40岁。
  • 热力烧伤331例(85%)最常见,但电击伤(11.7%)与冻伤(3.3%)的血管损伤发生率更高(P < 0.001)。
  • 60例(16.3%)检出血管损伤,其中21例(35%)接受伊洛前列素治疗。
  • 全部患者中20例(5.5%)截肢,伊洛前列素治疗组仅1例截肢(P < .001)。

关键数值与推荐

  • 血管损伤检出率16.3%(60/366),其中35%(21/60)接受伊洛前列素治疗。
  • 总截肢率5.5%(20/366),伊洛前列素组截肢1例,组间比较P < 0.001。
  • 电击伤血管损伤发生率11.7%,冻伤3.3%,与热力烧伤比较P < 0.001。

临床怎么用

  • 对烧伤合并血管损伤、存在截肢风险的患者,可考虑在评估后使用伊洛前列素以降低截肢率。
  • 电击伤与冻伤患者应重点排查血管损伤。

局限性

  • 为单中心回顾性研究,原文摘要未报告随机化、盲法及混杂因素校正情况。
  • 伊洛前列素组样本量较小(21例),结论需更大队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of our study was to demonstrate the decrease in amputation rates with iloprost treatment in patients who develop vascular injury due to burns. The data of 366 adult burn patients who were admitted to the emergency department of our hospital between 2016 and 2019 were analyzed. Demographic characteristics, burn factors, vascular examination findings, medical treatments, amputation rates, and levels were recorded. The amputation rates of the patients who were treated with iloprost and who were not treated with iloprost were compared. The mean age of 366 adult patients treated for burns was 37.8 ± 16.4 years, and of these patients, 220 (59.9%) were under 40 years of age. Although heat burns (n = 331.85%) were the most common burn etiology, it was found that the incidence of vascular injury was higher in burns caused by electricity (11.7%) and cold (3.3%) (P < 0.001). Vascular injury was detected in 60 (16.3%) of the patients and 21 (35%) of these patients were treated with iloprost. Amputation was observed in 20 (5.5%) of all burn patients, but only one of the patients treated with iloprost underwent amputation (P < .001). The individual and social impacts of amputations caused by burns are unquestionable. The authors are of the opinion that iloprost treatment is effective in reducing amputations due to burns.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Sevil FC, Sevil H, Tort M, et al. Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn. J Burn Care Res. 2021. PMID: 32735678. doi:10.1093/jbcr/iraa121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。